Vivoryon Therapeutics Company
%20.jpg)
Vivoryon Therapeutics is a Germany based biopharmaceutical company engaged in the activities of research and development, preclinical and clinical trials. It is focused on the development of therapeutic products for the treatment of Alzheimer's disease and cancer. The company's pipeline products includes PQ912, PQ1565 and PQ-family.
Last Funding Type:
Private Equity
Funding Status:
IPO
Headquarters:
Halle An Der Saale, Sachsen-Anhalt, Germany
Founded Date:
1-1
Investor Type:
For Profit
Total Funding:
$5M
Technology:
Geroscience
Employee Number:
101-250
Estimated Revenue:
$1M to $10M
Investors Number:
1
Industry:
Biotechnology, Health Care, Science and Engineering